<DOC>
	<DOC>NCT00196365</DOC>
	<brief_summary>This study is being conducted to evaluate the effects of treatment with Seasonique an extended-regimen oral contraceptive that utilizes low dose ethinyl estradiol during the typical hormone-free interval. Patients will receive 26 weeks of treatment. The overall study duration will be approximately 9 months. Patients will be required to record menstrual pain in a daily diary.</brief_summary>
	<brief_title>A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain</brief_title>
	<detailed_description />
	<mesh_term>Pelvic Pain</mesh_term>
	<mesh_term>Dysmenorrhea</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Ethinyl estradiol, levonorgestrel drug combination</mesh_term>
	<criteria>Moderate to severe menstrualrelated pain Regular spontaneous menstrual cycles Any contraindication to the use of oral contraceptives Treatment with an oral contraceptive in the last 3 months Previous treatment failure with an extended oral contraceptive regimen</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>cyclic pelvic pain</keyword>
	<keyword>dysmenorrhea</keyword>
</DOC>